Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Markstein

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Pharmacology|December 24, 1982
Dopamine receptor profile of co-dergocrine (Hydergine) and its componentsR Markstein
Journal of Neural Transmission|January 1, 1981
Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actionsR Markstein
European Journal of Pharmacology|November 11, 1983
Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptorsR Markstein
Journal De Pharmacologie|January 1, 1985
Hydergine: interaction with the neurotransmitter systems in the central nervous systemR Markstein
European Neurology|January 1, 1989
Pharmacological approaches in the treatment of senile dementiaR Markstein
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1984
Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleusR Markstein, T Hökfelt
Journal of Neurochemistry|April 1, 1986
Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectivelyS Urwyler, R Markstein
Journal of Neural Transmission. General Section|January 1, 1991
Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted miceK Kannari, R Markstein
European Journal of Pharmacology|July 26, 1988
Effect of neurotensin and its fragments neurotensin-(1-6) and neurotensin-(8-13) on dopamine release from cat striatumR Markstein, P Emson
Journal of Neural Transmission|January 1, 1983
In vitro effect of the racemic mixture and the (-)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptorR Markstein, D Lahaye
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Pharmacology|December 24, 1982
Dopamine receptor profile of co-dergocrine (Hydergine) and its componentsR Markstein
Journal of Neural Transmission|January 1, 1981
Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actionsR Markstein
European Journal of Pharmacology|November 11, 1983
Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptorsR Markstein
Journal De Pharmacologie|January 1, 1985
Hydergine: interaction with the neurotransmitter systems in the central nervous systemR Markstein
European Neurology|January 1, 1989
Pharmacological approaches in the treatment of senile dementiaR Markstein
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1984
Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleusR Markstein, T Hökfelt
Journal of Neurochemistry|April 1, 1986
Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectivelyS Urwyler, R Markstein
Journal of Neural Transmission. General Section|January 1, 1991
Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted miceK Kannari, R Markstein
European Journal of Pharmacology|July 26, 1988
Effect of neurotensin and its fragments neurotensin-(1-6) and neurotensin-(8-13) on dopamine release from cat striatumR Markstein, P Emson
Journal of Neural Transmission|January 1, 1983
In vitro effect of the racemic mixture and the (-)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptorR Markstein, D Lahaye
Pageof 5